AllianceBernstein
ALXA

AllianceBernstein’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

AllianceBernstein’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-206
Closed -$1K – 3806
2014
Q1 		$1K Buy
206
+3
+1% +$15 ﹤0.01% 3598
2013
Q4 		$1K Hold
203
– – ﹤0.01% 3408
2013
Q3 		$1K Buy
+203
New +$955 ﹤0.01% 3422

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

AllianceBernstein's ALXA Position: Q2 2014 in Review

AllianceBernstein sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2014, closing a stake of 206 shares — an estimated $1K sold.

AllianceBernstein first reported a position in ALXA in Q3 2013 and held it in 3 quarters. The position peaked at $1K in Q1 2014. 40 funds tracked by Wall St. Rank hold ALXA as of Q2 2014.

  • AllianceBernstein reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • AllianceBernstein sold 206 Alexza Pharmaceuticals Inc shares in Q2 2014, an estimated $1K.
  • AllianceBernstein first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 3 quarters.
  • AllianceBernstein's Alexza Pharmaceuticals Inc position peaked at $1K in Q1 2014.
  • 40 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.